Cargando…

Recent advances in primary immunodeficiency: from molecular diagnosis to treatment

The technological advances in diagnostics and therapy of primary immunodeficiency are progressing at a fast pace. This review examines recent developments in the field of inborn errors of immunity, from their definition to their treatment. We will summarize the challenges posed by the growth of next...

Descripción completa

Detalles Bibliográficos
Autores principales: Bucciol, Giorgia, Meyts, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096215/
https://www.ncbi.nlm.nih.gov/pubmed/32226610
http://dx.doi.org/10.12688/f1000research.21553.1
_version_ 1783510766955003904
author Bucciol, Giorgia
Meyts, Isabelle
author_facet Bucciol, Giorgia
Meyts, Isabelle
author_sort Bucciol, Giorgia
collection PubMed
description The technological advances in diagnostics and therapy of primary immunodeficiency are progressing at a fast pace. This review examines recent developments in the field of inborn errors of immunity, from their definition to their treatment. We will summarize the challenges posed by the growth of next-generation sequencing in the clinical setting, touch briefly on the expansion of the concept of inborn errors of immunity beyond the classic immune system realm, and finally review current developments in targeted therapies, stem cell transplantation, and gene therapy.
format Online
Article
Text
id pubmed-7096215
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-70962152020-03-27 Recent advances in primary immunodeficiency: from molecular diagnosis to treatment Bucciol, Giorgia Meyts, Isabelle F1000Res Review The technological advances in diagnostics and therapy of primary immunodeficiency are progressing at a fast pace. This review examines recent developments in the field of inborn errors of immunity, from their definition to their treatment. We will summarize the challenges posed by the growth of next-generation sequencing in the clinical setting, touch briefly on the expansion of the concept of inborn errors of immunity beyond the classic immune system realm, and finally review current developments in targeted therapies, stem cell transplantation, and gene therapy. F1000 Research Limited 2020-03-19 /pmc/articles/PMC7096215/ /pubmed/32226610 http://dx.doi.org/10.12688/f1000research.21553.1 Text en Copyright: © 2020 Bucciol G and Meyts I http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Bucciol, Giorgia
Meyts, Isabelle
Recent advances in primary immunodeficiency: from molecular diagnosis to treatment
title Recent advances in primary immunodeficiency: from molecular diagnosis to treatment
title_full Recent advances in primary immunodeficiency: from molecular diagnosis to treatment
title_fullStr Recent advances in primary immunodeficiency: from molecular diagnosis to treatment
title_full_unstemmed Recent advances in primary immunodeficiency: from molecular diagnosis to treatment
title_short Recent advances in primary immunodeficiency: from molecular diagnosis to treatment
title_sort recent advances in primary immunodeficiency: from molecular diagnosis to treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096215/
https://www.ncbi.nlm.nih.gov/pubmed/32226610
http://dx.doi.org/10.12688/f1000research.21553.1
work_keys_str_mv AT bucciolgiorgia recentadvancesinprimaryimmunodeficiencyfrommoleculardiagnosistotreatment
AT meytsisabelle recentadvancesinprimaryimmunodeficiencyfrommoleculardiagnosistotreatment